Machine learning IDs mammal species with the potential to spread SARS-CoV-2

COVID-19 research and resources

Arvind Varsani

Machine learning IDs mammal species with the potential to spread SARS-CoV-2

Back and forth transmission of SARS-CoV-2 between people and other mammals increases the risk of new variants and threatens efforts to control COVID-19. A new study, published today in Proceedings of the Royal Society B, used a novel modelling approach to predict the zoonotic capacity of 5,400 mammal species, extending predictive capacity by an order of magnitude.

COVID-19 and the 2021 global supply chain crisis

Record queues of container ships wait at anchor outside the Port of Los Angeles. A 20-mile traffic jam clogs rail lines in Chicago. Store shelves are bare and shortages of numerous products

Efrem Lim

New funding advances Biodesign SARS-CoV-2 research

Biodesign researcher Dr. Efrem Lim began studying the human virome long before the arrival of SARS-CoV-2 and the global pandemic. His innovative use of high-throughput viral sequencing and functional studies of viral

SARS-CoV-2: A theme and variations

The celebrations were well underway. America seemed to be emerging from the depths of the COVID-19 crisis, following some of the darkest days in the nation’s history. A vast reduction in infections, hospitalizations, and fatalities, driven by improved therapies and above all, a suite of highly effective vaccines, had brought a collective sigh of relief. The July 4th festivities were euphorically anticipated, marking not only the nation’s independence from colonial rule but its...

COVID-19: A one-year review

As COVID-19 threatened the lives, livelihoods and mental well-being of people worldwide, Arizona State University met the unprecedented challenges with speed, agility and, most of all, teamwork. As part of

Arizona Town Hall Meeting on COVID-19 Vaccine Safety

Scientists at Arizona State University and University of Arizona have joined a national effort to educate the general public about COVID-19 vaccination. Leading Arizona's discussions will be: Felicia Goodrum, PhD, University of Arizona College of Medicine James Alwine, PhD, University of Arizona Grant McFadden, PhD, director, Biodesign Center for Immunotherapy, Vaccines and Virotherapy Brenda Hogue, PhD, Biodesign Center for Immunotherapy, Vaccines and...

Karen Anderson

Variances in critical protein may guide fate of those infected with SARS CoV-2

Of the many perplexing questions surrounding SARS CoV-2, a mysterious new pathogen that has killed an estimated 2.6 million people worldwide, perhaps the most insistent is this: why does the illness

ASU’s unsung heroes

Workers on one of the front lines of the pandemic keep ASU's campuses safe and running Everything the rest of us have tried to avoid for the past nine months

A dose of facts: Answering your COVID-19 vaccine questions

​Over 170 million people in the U.S. are now fully vaccinated against COVID-19 -- more than half of the country's population. But as the virus evolves and new variants emerge,

Volunteer administering COVID-19 test in drive through testing site.

What kind of COVID-19 test do I need and where can I get it?

Variety of testing methods add to arsenal against spread of deadly coronavirus A second wave of COVID-19 is rising in Arizona and across the U.S., causing exponential growth of new

Joshua LaBaer and research team in laboratory, all wearing masks and lab coats.

State recognizes ASU Biodesign Institute’s response to COVID-19 with Innovator of the Year Award

Since the rise of COVID-19 in our state last spring, the Arizona State University Biodesign Institute has worked tirelessly to respond, in particular by providing rapid public testing for the virus and

ASU ignites discovery to conquer COVID-19: the first six months

In early 2020, hundreds of ASU researchers, faculty, staff and students mobilized at breakneck speed to apply their skills, tools and expertise to a singular goal: stopping the deadly coronavirus